Market Research Reports and Industry Reports

John Hopkins University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

John Hopkins University (JHU) is an educational service provider that offers undergraduate, graduate, summer and distance education programs. The university offers education programs in the areas of arts and sciences, engineering, business, medicine, nursing, public health, and advanced international studies. It conducts research services on applied physics, projects administration, natural sciences, engineering, technology, global research, and others. JHU offers undergraduate and postgraduate research services through its incubation center in the areas of drug development for cancer, mobile health platform, device to detect and prevent blindness caused by diabetes. The university operates through its campuses in the Baltimore-Washington region including Homewood, Harbor East, Peabody Campus, SAIS Washington, SAIS Bologna and Montgomery County. JHU is headquartered in Baltimore, Maryland, the US.

John Hopkins University - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

3
List of Tables 5
List of Figures 5
John Hopkins University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
John Hopkins University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
John Hopkins University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
John Hopkins University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
John Hopkins University, Medical Devices Deals, 2011 to YTD 2017 12
John Hopkins University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 14
John Hopkins University, Pharmaceuticals & Healthcare, Deal Details 17
Partnerships 17
Eisai Expand Licensing Agreement with Johns Hopkins University 17
Morphotek Enters into Agreement with Johns Hopkins University School of Medicine 18
AbbVie Enters into Research Agreement with Johns Hopkins University School of Medicine 19
Bristol-Myers Squibb Company Enters into Agreement with John Hopkins University 20
Sanofi Genzyme Enters into Research Agreement with Johns Hopkins School of Medicine 21
Bayer HealthCare Enters into Agreement with Johns Hopkins University 22
VLP Therapeutics Enters into Research Agreement with Johns Hopkins University Bloomberg School of Public Health 23
MaxCyte Enters into Research Agreement with Johns Hopkins University 24
Compugen Enters into Research Agreement with Johns Hopkins University School of Medicine 25
Saudi Aramco Forms Joint Venture Agreement With Johns Hopkins Medicine 26
MedImmune Enters Into Research Agreement With Johns Hopkins University 27
Imec Enters Into Co-Development Agreement With Johns Hopkins University 28
US Patent Innovations Enters Into Technology Transfer Agreement With George Washington University And Johns Hopkins University 29
MediGene Enters Into Co-Development Agreement With Johns Hopkins University 30
Johns Hopkins Brain Science Institute Enters Into An Agreement With Ortho-McNeil-Janssen 31
Licensing Agreements 32
Canopy Biosciences Enters into Licensing Agreement with Washington University in St. Louis and Johns Hopkins University 32
Medicines Patent Pool Enters into Licensing Agreement with John Hopkins University 33
Allakos Expands its Licensing Agreement with Johns Hopkins University School of Medicine 34
Progenics Pharmaceuticals Enters into Licensing Agreement with Johns Hopkins University 35
Cerecor Enters Into Option For Licensing Agreement With Johns Hopkins University For DAAO Inhibitors 36
NexImmune Enters into Licensing Agreement with John Hopkins University 37
Pharos Biologicals Signs Licensing Agreement with University School of Medicine 38
Advanced Accelerator Applications Enters into Licensing Agreement with Johns Hopkins University 39
Good Start Genetics Expands Licensing Agreement with Johns Hopkins University 40
Blade Therapeutics Enters into Licensing Agreement with Johns Hopkins University School of Medicine 41
PapGene Enters into Licensing Agreement with Johns Hopkins University 42
Tokai Pharma Enters into Licensing Agreement with Johns Hopkins University 43
Good Start Genetics Enters into Licensing Agreement with Johns Hopkins University 44
Max Biopharma Enters Into License Agreement With UCLA And Johns Hopkins University For Small Molecule Technology 45
GrayBug Enters into Licensing Agreement with Johns Hopkins University 46
ImmunoCellular Amends Licensing Agreement With Johns Hopkins University 47
Epi Pharma Amends Licensing Agreement with John Hopkins University, Wayne State University and Wisconsin Alumni Research Foundation 48
Aduro BioTech Enters into Licensing Agreement with Johns Hopkins University 49
John Hopkins University - Key Competitors 50
John Hopkins University - Key Employees 51
John Hopkins University - Locations And Subsidiaries 52
Head Office 52
Other Locations & Subsidiaries 52
Joint Venture 54
Recent Developments 55
Government and Public Interest 55
Oct 12, 2017: Johns Hopkins Scientists Develop Experimental Nano-Chemo Particle to Treat Bladder Cancer 55
Oct 06, 2017: FDA awards 15 grants for clinical trials to stimulate product development for rare diseases 57
Sep 21, 2017: Grant funds chemotherapy-free breast cancer therapy research 59
Sep 20, 2017: Johns Hopkins Professors to Receive $13.4 Million for MS Research 60
Sep 19, 2017: CPRIT awards $34M to UTSW for cancer research recruitment 61
Jun 12, 2017: Study Calls For Use of Better Outcome Measures in Clinical Trials for Fragile X Syndrome and Other Neurodevelopmental Disorders 63
Jun 07, 2017: New Class of Double-Duty Magnetic Nanoparticles Engineered to Lower Cancers Defenses While Firing up Immune System 65
May 30, 2017: Reservoirs of Latent HIV Can Grow Despite Effective Therapy, Study Shows 67
Apr 18, 2016: Cellular Trojan horse yields potential cancer treatment 69
Feb 12, 2016: Gene signature could lead to a new way of diagnosing Lyme 70
Other Significant Developments 71
Mar 30, 2016: Immunotherapy and Melanoma Research Get Big Boost with Bloomberg-Kimmel Institute 71
Appendix 72
Methodology 72
About GlobalData 72
Contact Us 72
Disclaimer 72

List Of Tables

List of Tables
John Hopkins University, Pharmaceuticals & Healthcare, Key Facts 2
John Hopkins University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
John Hopkins University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
John Hopkins University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
John Hopkins University, Deals By Therapy Area, 2011 to YTD 2017 10
John Hopkins University, Medical Devices Deals, 2011 to YTD 2017 12
John Hopkins University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 14
Eisai Expand Licensing Agreement with Johns Hopkins University 17
Morphotek Enters into Agreement with Johns Hopkins University School of Medicine 18
AbbVie Enters into Research Agreement with Johns Hopkins University School of Medicine 19
Bristol-Myers Squibb Company Enters into Agreement with John Hopkins University 20
Sanofi Genzyme Enters into Research Agreement with Johns Hopkins School of Medicine 21
Bayer HealthCare Enters into Agreement with Johns Hopkins University 22
VLP Therapeutics Enters into Research Agreement with Johns Hopkins University Bloomberg School of Public Health 23
MaxCyte Enters into Research Agreement with Johns Hopkins University 24
Compugen Enters into Research Agreement with Johns Hopkins University School of Medicine 25
Saudi Aramco Forms Joint Venture Agreement With Johns Hopkins Medicine 26
MedImmune Enters Into Research Agreement With Johns Hopkins University 27
Imec Enters Into Co-Development Agreement With Johns Hopkins University 28
US Patent Innovations Enters Into Technology Transfer Agreement With George Washington University And Johns Hopkins University 29
MediGene Enters Into Co-Development Agreement With Johns Hopkins University 30
Johns Hopkins Brain Science Institute Enters Into An Agreement With Ortho-McNeil-Janssen 31
Canopy Biosciences Enters into Licensing Agreement with Washington University in St. Louis and Johns Hopkins University 32
Medicines Patent Pool Enters into Licensing Agreement with John Hopkins University 33
Allakos Expands its Licensing Agreement with Johns Hopkins University School of Medicine 34
Progenics Pharmaceuticals Enters into Licensing Agreement with Johns Hopkins University 35
Cerecor Enters Into Option For Licensing Agreement With Johns Hopkins University For DAAO Inhibitors 36
NexImmune Enters into Licensing Agreement with John Hopkins University 37
Pharos Biologicals Signs Licensing Agreement with University School of Medicine 38
Advanced Accelerator Applications Enters into Licensing Agreement with Johns Hopkins University 39
Good Start Genetics Expands Licensing Agreement with Johns Hopkins University 40
Blade Therapeutics Enters into Licensing Agreement with Johns Hopkins University School of Medicine 41
PapGene Enters into Licensing Agreement with Johns Hopkins University 42
Tokai Pharma Enters into Licensing Agreement with Johns Hopkins University 43
Good Start Genetics Enters into Licensing Agreement with Johns Hopkins University 44
Max Biopharma Enters Into License Agreement With UCLA And Johns Hopkins University For Small Molecule Technology 45
GrayBug Enters into Licensing Agreement with Johns Hopkins University 46
ImmunoCellular Amends Licensing Agreement With Johns Hopkins University 47
Epi Pharma Amends Licensing Agreement with John Hopkins University, Wayne State University and Wisconsin Alumni Research Foundation 48
Aduro BioTech Enters into Licensing Agreement with Johns Hopkins University 49
John Hopkins University, Key Competitors 50
John Hopkins University, Key Employees 51
John Hopkins University, Other Locations 52
John Hopkins University, Subsidiaries 52
John Hopkins University, Joint Venture 54

APA – Antigua Port Redevelopment – Saint John - Project Profile

Synopsis APA Antigua Port Redevelopment Saint John - Project Profile contains information on the scope of the project including project overview and location. The profile also details project ownership

USD 75View Report

IOL/TRP/EEPL – Saint John Marine Terminal – New Brunswick - Project Profile

Synopsis IOL/TRP/EEPL Saint John Marine Terminal New Brunswick - Project Profile contains information on the scope of the project including project overview and location. The profile also details project

USD 75View Report

John Hopkins University Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

John Hopkins University Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile,

USD 200View Report

John Hopkins University - Medical Equipment - Deals and Alliances Profile

John Hopkins University (JHU) is an educational service provider that offers undergraduate, graduate, summer and distance education programs. The university offers education programs in the areas of arts and sciences,

USD 250View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
Country Code.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Nov 2017
No. of Pages :72
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube